These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8723173)
41. Left ventricular performance after intravenous infusion of captopril in patients with congestive heart failure. Arcidiacono G; Asmundo GO; Battaglia E; Bordignon E; Calogero AE; Cuscunà S; Floridia S; Vigo G; Ossino AM; Gurgone G Minerva Cardioangiol; 1995; 43(11-12):481-4. PubMed ID: 8710137 [TBL] [Abstract][Full Text] [Related]
42. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815 [TBL] [Abstract][Full Text] [Related]
43. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934 [TBL] [Abstract][Full Text] [Related]
44. Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. Packer M; Lee WH; Medina N; Yushak M Ann Intern Med; 1986 Feb; 104(2):147-54. PubMed ID: 2936291 [TBL] [Abstract][Full Text] [Related]
45. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
46. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study. Lee AF; MacFadyen RJ; Struthers AD Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954 [TBL] [Abstract][Full Text] [Related]
47. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Packer M; Lee WH; Kessler PD Circulation; 1986 Oct; 74(4):766-74. PubMed ID: 3019586 [TBL] [Abstract][Full Text] [Related]
48. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease. Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392 [TBL] [Abstract][Full Text] [Related]
49. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis]. Radzevich AE; Ditiatkov AE; Tikhonov VA Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951 [TBL] [Abstract][Full Text] [Related]
50. Predictive value of 99Tcm-DTPA captopril scintigraphy in patients with a solitary kidney and reduced kidney function. Van de Wiele C; Brans B; Vanholder R; Hoeben H; Van Laere K; Dierckx RA Nucl Med Commun; 1999 Mar; 20(3):263-6. PubMed ID: 10093076 [TBL] [Abstract][Full Text] [Related]
51. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)]. Goto A Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093 [TBL] [Abstract][Full Text] [Related]
52. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972 [TBL] [Abstract][Full Text] [Related]
53. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Awan NA; Evenson MK; Needham KE; Win A; Mason DT Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100 [TBL] [Abstract][Full Text] [Related]
55. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure. O'Toole L; Stewart M; Padfield P; Channer K J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506 [TBL] [Abstract][Full Text] [Related]
56. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor. Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914 [TBL] [Abstract][Full Text] [Related]
57. Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure. Manolis AJ; Olympios C; Sifaki M; Handanis S; Cokkinos D; Bresnahan M; Gavras I; Gavras H Hypertension; 1997 Jan; 29(1 Pt 2):525-30. PubMed ID: 9039154 [TBL] [Abstract][Full Text] [Related]
58. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril]. Ohmura I; Maki E; Naruse T; Ikeda N; Asami T; Sagawa N Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926 [TBL] [Abstract][Full Text] [Related]
59. [Effect of captopril in chronic aortic insufficiency]. Klepzig H; Mildenberger D; Baum R; Jungmann E; Standke R; Siede WH; Maul FD; Hör G; Kaltenbach M Z Kardiol; 1986 May; 75(5):283-90. PubMed ID: 3526733 [TBL] [Abstract][Full Text] [Related]
60. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure. Levine TB; Cohn JN Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]